IL10 and systemic lupus erythematosus: These studies, combined with the observations that continuous administration of anti-IL-10 demonstrated a delay in onset of autoimmunity in NZB/W F1 mice [5], and anti-IL-10 mAb administered to six steroid-dependent patients with SLE was shown to have a beneficial effect on disease activity [6], suggest that this cytokine may promote disease.